)
Edge11 Sep 2026
Texas Pacific Land Corporation: Keeper of the Permian Basin
Land once granted to a failed 19th-century railroad now generates royalties for Texas Pacific Land Corporation across the Permian Basin.
First Tracks Biotherapeutics
First Tracks Biotherapeutics (TRAX) investor relations material
First Tracks Biotherapeutics Wells Fargo 21st Annual Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Wells Fargo 21st Annual Healthcare Conference summary9 Sep, 2026
Company formation and funding
Spun out R&D operations and employees into a new entity in April, focusing on three development-stage assets.
Raised capital in April, securing cash runway into Q2 2028.
Lead program ANB033 and clinical rationale
ANB033 targets CD122, blocking both IL-15 and IL-2 signaling, with potential across multiple autoimmune diseases.
Chosen for celiac disease due to strong biological rationale, lack of approved therapies, and large market opportunity.
Dual mechanism may offer differentiation and greater potency over IL-15-only approaches.
Celiac disease clinical trials
Phase I-B trial includes two cohorts: gluten challenge (cohort 1) and mucosal healing (cohort 2), with protocol broadened to include more patients.
Primary endpoints are changes in villus height-to-crypt depth ratio (Vh:Cd) and intraepithelial lymphocytes (IELs).
Data from cohort 1 expected in Q4, cohort 2 in Q1 next year.
Emphasis on statistical significance in Vh:Cd and trends in mucosal healing over short trial periods.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from First Tracks Biotherapeutics
- Q2 2026 net loss narrowed to $33.4M, $168M cash, and ANB033 trial advanced with FDA Fast Track.TRAX
Q2 2026 - Biotech spin-off with immunology focus registers shares for resale; no proceeds to company.TRAXRegistration filing
- ANB033 and rosnilimab advance as antibody therapies, with pivotal data expected in 2024.TRAXJefferies Global Healthcare Conference 2026
- Lead antibody programs show strong efficacy and safety in autoimmune diseases, targeting large markets.TRAXCorporate presentation
- Ended Q1 2026 with $248.5M cash, $50.5M net loss, and advanced clinical pipeline post-spin-off.TRAXQ1 2026
Next First Tracks Biotherapeutics earnings date
Q3 202612 Nov, 2026
First Tracks Biotherapeutics
Next First Tracks Biotherapeutics earnings date
Q3 202612 Nov, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage